Equity intelligence report • June 03, 2026
HCA Healthcare, Inc. continues to face significant financial challenges despite recent revenue growth, reporting a 6.9% increase in Q1 2022 revenues to $14.945 billion. However, net income has dropped 10.6% year-over-year to $1.273 billion, alongside a troubling decline in operating cash flows. The company is reacting to a regulatory setback that blocked its acquisition of five Utah hospitals by forming a strategic joint venture with McKesson to bolster oncology research, which may help mitigate some pressures. The outlook remains cautious as HCA grapples with rising operational costs, a recent 15.41% stock decline, and an anticipated earnings drop, prompting analysts to express concern regarding its future stability.
Click a month on the chart to update the report below.
